Cargando…
TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer
Endometrial cancer (EC) is the most common gynecological malignancy worldwide. However, the molecular mechanisms underlying EC progression are still largely unknown, and chemotherapeutic options for EC patients are currently very limited. In this study, we found that histone methyltransferase EZH2 a...
Autores principales: | Gui, Tao, Liu, Ming, Yao, Bing, Jiang, Haiqin, Yang, Dongjun, Li, Qixiang, Zeng, Xiangwei, Wang, Ying, Cao, Jian, Deng, Yexuan, Li, Xinyu, Xu, Peipei, Zhou, Liqin, Li, Dake, Wang, Zhihui, Zen, Ke, Huang, David C. S., Chen, Bing, Wan, Guiping, Zhao, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630057/ https://www.ncbi.nlm.nih.gov/pubmed/34175897 http://dx.doi.org/10.1038/s41418-021-00824-w |
Ejemplares similares
-
Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing
por: O’Geen, Henriette, et al.
Publicado: (2022) -
The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer
por: Kodach, Liudmila L., et al.
Publicado: (2010) -
PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling
por: Yao, Bing, et al.
Publicado: (2021) -
Correction to: PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling
por: Yao, Bing, et al.
Publicado: (2021) -
DNMT3A Mutation-Induced CDK1 Overexpression Promotes Leukemogenesis by Modulating the Interaction between EZH2 and DNMT3A
por: Yang, Ying, et al.
Publicado: (2021)